What Tree Does MDMA Really Come From?

The tree most famously linked to MDMA is the sassafras, specifically the North American species Sassafras albidum, whose root bark can be more than 85% safrole by essential oil weight. Safrole is the natural starting material that clandestine chemists have historically used to produce MDMA. But calling MDMA a “sassafras drug” oversimplifies the picture: safrole occurs in several unrelated tree and plant genera across the tropics, and increasingly, the drug is manufactured without any plant material at all.

Sassafras and Safrole

Sassafras albidum is a deciduous tree native to eastern North America, recognizable by its mitten-shaped leaves and spicy-sweet bark. It belongs to the laurel family (Lauraceae) and has a long history in folk medicine and as a flavoring, most famously in old-fashioned root beer. The reason it matters to the MDMA story is one chemical compound: safrole, a naturally occurring phenylpropene concentrated in the root bark and root wood.

Chemical analyses of sassafras root bark consistently find safrole as the dominant component of the essential oil, typically making up roughly 60 to 89% of the total oil depending on extraction method and plant sample.1PubMed. Chemical composition of essential oil from the root bark of Sassafras albidum2Journal of Essential Oil Research. Composition of the essential oil from the root of Sassafras albidum (Nutt.) Nees One analysis identified about 30 compounds in the root bark oil, with safrole at 85%, followed by much smaller amounts of camphor and methyleugenol. That overwhelming dominance of a single useful compound made sassafras a convenient natural feedstock for anyone who wanted safrole in bulk, whether for legitimate industrial purposes or for illicit drug manufacturing.

Other Trees and Plants That Produce Safrole

Sassafras gets the headlines, but safrole is surprisingly widespread in the plant kingdom. It appears in several genera spread across different continents and different plant families.3Flavour and Fragrance Journal. Review on safrole: identity shift of the ‘candy shop’ aroma to a carcinogen and deforester The most significant sources beyond sassafras include:

  • Ocotea species: Several trees in the genus Ocotea, also members of the laurel family, grow in the tropical forests of South America and Southeast Asia. Ocotea cymbarum (Brazilian sassafras) and Ocotea odorifera have been commercially important sources of safrole-rich oil, particularly in Brazil.
  • Cinnamomum species: Some species related to common cinnamon, especially Cinnamomum parthenoxylon (found in Southeast Asia), contain high concentrations of safrole in their wood and bark. Cambodian sassafras oil, which has drawn international attention for its role in MDMA precursor supply, comes from trees in this genus.
  • Piper hispidinervum: This Amazonian shrub, sometimes called long pepper, can yield essential oils with safrole concentrations around 85%, rivaling sassafras root bark itself.4Industrial Crops and Products. Chemical composition and amoebicidal activity of Piper hispidinervum (Piperaceae) essential oil
  • Myristica fragrans: Nutmeg contains small amounts of safrole along with its more famous psychoactive compound myristicin. The concentrations are too low for practical extraction, but its presence illustrates how widely distributed safrole is in nature.

The fact that safrole appears in so many unrelated plant lineages reflects a common evolutionary strategy. Plants produce phenylpropenes as part of their chemical defense against herbivores and pathogens. Safrole, with its distinctive sweet aroma, is one of many such compounds that evolved independently in different plant families. From a drug-manufacturing perspective, the diversity of botanical sources has meant that law enforcement efforts to control safrole supply face a moving target: shut down one source, and producers can pivot to another tree on another continent.

How Safrole Becomes MDMA

Safrole itself has no psychoactive properties. Converting it into MDMA requires several chemical steps, and the specific route matters because it determines what impurities end up in the final product. Forensic chemists study these impurity profiles to trace batches of MDMA back to their manufacturing method.

The classic approach starts with safrole extracted from plant material. That safrole is then converted into an intermediate compound called MDP2P (3,4-methylenedioxyphenyl-2-propanone), which can be done through several different chemical reactions. In the final step, MDP2P undergoes a process called reductive amination, where a methylamine group is added to produce MDMA.5PubMed. Organic impurity profiling of 3,4-methylenedioxymethamphetamine (MDMA) synthesised from catechol The whole pathway, from tree bark to finished tablet, involves organic chemistry that is well-documented in forensic literature but requires genuine lab skills and equipment.

What makes the forensic side interesting is that different starting materials leave different chemical fingerprints. When MDMA is synthesized from safrole derived from sassafras versus, say, from catechol or eugenol (compounds available from non-botanical industrial sources), the impurity profiles differ in identifiable ways. One study examined MDMA made from catechol and eugenol via a safrole intermediate and found distinct sets of roughly eleven to twelve organic impurities depending on the synthesis route.6Forensic Science International. Organic impurity profiling of 3,4-methylenedioxymethamphetamine (MDMA) synthesised from catechol and eugenol via 4-allylcatechol These chemical signatures let forensic analysts link seized tablets to manufacturing methods even when they cannot trace the physical supply chain.

The Move Away from Trees

While the botanical origins of MDMA make for a compelling narrative, the reality of modern clandestine manufacturing has been steadily shifting away from plant-derived safrole. International drug control bodies classified safrole and safrole-rich oils as controlled precursor chemicals decades ago, making large-scale extraction from trees increasingly risky for producers. In response, clandestine laboratories have adopted what chemists call “pre-precursors,” which are synthetic chemicals that are not themselves controlled but can be converted into the same intermediates that safrole would yield.

The most prominent of these pre-precursors are glycidate esters, specifically compounds like methyl 3-(3,4-methylenedioxyphenyl)-2-methyl glycidate, sometimes known by its shorthand PMK glycidate. These substances can be converted into MDP2P in a laboratory without ever touching a sassafras tree. Forensic seizures in places like Australia have confirmed that these glycidate pre-precursors are now showing up in clandestine labs as the starting material of choice.7Drug Testing and Analysis. An Investigation Into the Yields of 3,4‐Methylenedioxyphenyl‐2‐propanone (MDP2P) From Glycidate Pre‐Precursors

This shift has practical implications. It means that for a growing share of MDMA on the market, no tree was involved at any stage of production. The drug’s chemistry is fully synthetic from start to finish. The “sassafras tree” origin story, while historically accurate and still relevant in some regions, no longer describes the dominant manufacturing reality in major markets. European and Australian forensic agencies have noted the glycidate trend for years, and it continues to expand as precursor regulations tighten.

A Brief History of MDMA’s Synthesis

MDMA was first synthesized in 1912 at the German pharmaceutical company Merck by a chemist named Anton Köllisch.8PubMed. The early history of “Ecstasy” The popular version of the story, repeated in countless media accounts, claimed for years that Merck developed MDMA as an appetite suppressant. Detailed historical research drawing on Merck’s original laboratory notebooks tells a different story. Köllisch was working on a new method to synthesize hydrastinine, a substance used to stop bleeding. MDMA appeared as a chemical intermediate in that process, not as a drug intended for human use. Merck patented the preparation method in 1912 but apparently had little interest in MDMA itself, and the compound was not pharmacologically tested at the time.9Addiction. The origin of MDMA (ecstasy) revisited: the true story reconstructed from the original documents

The original synthetic route began with a bromination step followed by displacement with methylamine to produce the MDMA molecule.10PubMed Central. Dark Classics in Chemical Neuroscience: 3,4-Methylenedioxymethamphetamine (MDMA) MDMA then sat in obscurity for decades. It resurfaced in the 1970s when the American chemist Alexander Shulgin independently synthesized it, tested it on himself, and promoted its use in psychotherapy. By the 1980s, it had migrated into the recreational drug scene under the name “Ecstasy,” and from there the demand for safrole as a precursor skyrocketed.

The gap between MDMA’s accidental creation in a German lab and its eventual recreational popularity spans more than 60 years. During that time, the compound was essentially forgotten. This history matters because it underscores that MDMA was never derived from sassafras in any folk-medicine or traditional sense. It is a fully synthetic molecule that happens to start with a plant-derived chemical.

The Environmental Cost of Safrole Harvesting

The demand for safrole-rich oil driven by MDMA manufacturing has had real consequences for forests, particularly in Southeast Asia and South America. In Cambodia, large-scale distillation operations in remote forests targeted Cinnamomum trees for their safrole-rich wood. Entire trees were felled and fed into makeshift distillation equipment. The scale of the problem drew attention from international conservation groups by the mid-2000s.

A review of safrole’s shifting identity, from candy flavoring to carcinogen to deforestation driver, describes how accelerating demand for the recreational drug market encouraged unscientific harvesting, illegal production, and trading of safrole-rich oils, leading to massive deforestation in affected regions.3Flavour and Fragrance Journal. Review on safrole: identity shift of the ‘candy shop’ aroma to a carcinogen and deforester Government authorities in multiple countries have since moved to restrict the production and harvesting of safrole-bearing plants.

In Brazil, several Ocotea species that produce safrole are now classified as endangered. Their populations were already stressed by habitat loss in the Atlantic Forest before safrole demand compounded the pressure. Climate modeling suggests these species face further declines, with suitable habitat projected to shrink by roughly a third to more than 80% by the end of the century depending on the species and the emissions scenario.11Forest Ecology and Management. Present and future distribution of endangered and economically important Ocotea species in the Brazilian Atlantic Forest: Implications for conservation and restoration The combination of past exploitation for safrole and ongoing habitat destruction from agriculture and forestry has left some of these trees in a precarious position.

The irony is that the shift to synthetic pre-precursors described earlier may, in a roundabout way, reduce pressure on these forests. If clandestine chemists can make MDMA without any tree-derived safrole, the economic incentive to fell Cinnamomum or Ocotea trees for their oil diminishes. Whether that actually translates to reduced deforestation depends on local economics, enforcement, and whether safrole oil is also being harvested for other purposes.

Safrole Beyond MDMA

It would be a mistake to think of safrole as purely a drug precursor. Before it became synonymous with the MDMA supply chain, safrole had a long commercial life in legitimate industries. For much of the twentieth century, it was used as a flavoring agent in foods, beverages, and medicines. Root beer originally got its distinctive taste from sassafras root bark. That use ended in the 1960s when animal studies linked safrole to liver cancer, prompting the U.S. Food and Drug Administration to ban safrole as a food additive.

The cancer risk comes from the way the body processes safrole. Once ingested, it can be metabolized into a reactive form that binds to DNA, forming what are called genotoxic adducts, essentially chemical damage to the genetic code that can initiate cancerous changes.12PubMed Central. Biological reactive intermediates (BRIs) formed from botanical dietary supplements This toxicology is relevant to the sassafras-tea trend that periodically surfaces in wellness circles. Drinking sassafras bark tea delivers safrole directly, and while the dose in a single cup is small, the carcinogenic mechanism is well established in animal models.

Analytical methods have been developed specifically to detect safrole and its related compounds in sassafras-derived herbal products, a reflection of ongoing concern that these products expose consumers to a known carcinogen.13Journal of AOAC INTERNATIONAL. Liquid Chromatographic Determination of Safrole in Sassafras-Derived Herbal Products

The most significant ongoing legitimate use of safrole is in the production of piperonyl butoxide (PBO), a synergist added to insecticide formulations. PBO does not kill insects on its own, but it dramatically boosts the effectiveness of pyrethrins and pyrethroids, the active ingredients in many household and agricultural insecticides. Safrole provides the core chemical structure of PBO, and global demand for the synergist continues to grow alongside the expanding pyrethroid insecticide market.14ScienceDirect. Piperonyl Butoxide This means that even in a world where MDMA manufacturing has moved on to synthetic pathways, safrole remains a commercially valuable chemical, and the trees that produce it remain targets for extraction.

Why the “Sassafras Tree” Answer Is Both Right and Outdated

If someone asks which tree MDMA comes from, the truthful answer involves a tension between history and current practice. Historically, the sassafras tree and its tropical relatives were the starting point. Safrole distilled from their bark and wood fed a supply chain that produced much of the world’s MDMA through the 1990s and into the 2000s. That era is fading. The dominant manufacturing route in Europe and Australia now begins with fully synthetic chemicals ordered from chemical suppliers, often in China, and the final MDMA molecule never had any botanical ancestor.

The sassafras connection persists in popular culture partly because it is a vivid, concrete image: a common backyard tree in the eastern United States linked to a notorious party drug. The reality is messier. Even during the peak of plant-derived production, much of the safrole came from tropical Cinnamomum and Ocotea species rather than North American sassafras. And today, the tree might not be involved at all. For someone who encounters sassafras in the wild and wonders whether it is “the MDMA tree,” the answer is that it could have been, in principle, but a single sassafras in your yard contains a trivially small amount of safrole compared to what any manufacturing operation would need, and the chemistry to get from bark to finished drug is far from trivial.

Sassafras in North American Ecology and Culture

Sassafras albidum is a common understory and edge tree from southern Ontario to central Florida. It colonizes disturbed ground quickly, produces small blue-black fruits eaten by birds, and spreads aggressively through root suckers, often forming dense thickets. It was among the first New World exports to Europe: early colonists shipped sassafras bark across the Atlantic in the belief that it could cure syphilis, a claim that proved baseless but that made the tree briefly more valuable per pound than tobacco.

Today, sassafras is most commonly encountered as a volunteer tree in fencerows and woodland margins. Its leaves turn vivid orange and red in autumn, and the aromatic bark and twigs still see occasional use in traditional Appalachian cooking, particularly for filé powder, a sassafras leaf product used to thicken gumbo. The leaves, unlike the root bark, contain very little safrole, so filé powder does not carry the same carcinogenic concern that root bark tea does. This distinction, leaves versus root bark, is worth knowing for anyone interested in traditional uses of the tree.

The broader story of sassafras illustrates how a single plant can occupy radically different roles depending on the era and the audience. It has been a colonial wonder drug, a beloved flavoring, a banned carcinogen, and a drug precursor, each identity layered on top of the last. The tree itself has not changed. What keeps shifting is what humans decide to extract from it and why.